Related Experiment Video
Updated: May 18, 2026

A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions
Published on: April 18, 2025
Anticancer peptides and proteins: a panoramic view
M S Libério1, G A Joanitti, W Fontes
1Toxinology Laboratory, Department of Physiological Sciences, Institute of Biology, University of Brasilia, Brasilia/DF, Brazil, 70910-900.
Abstract:
Despite progress in understanding carcinogenesis, cancer is still a major cause of morbidity and mortality worldwide. Treatment is complicated by the resistance to chemotherapeutics acquired by tumors, ability to repair damaged DNA, alteration of the interaction between drug and its target, and defects in the machinery that leads to apoptosis. The development of novel therapies based on biologically active peptides, especially antimicrobial peptides (AMPs), and proteins has emerged as a new strategy to defeat cancer.
Insights
Antimicrobial peptides (AMPs) offer a novel strategy against cancer, overcoming treatment resistance mechanisms like DNA repair and apoptosis evasion. These biologically active peptides show promise in developing new cancer therapies.
Area of Science:
- Oncology
- Biochemistry
- Molecular Biology
Background:
- Cancer remains a leading global cause of death despite advances in understanding carcinogenesis.
- Tumor resistance to chemotherapy is a major challenge, stemming from DNA repair, altered drug interactions, and apoptosis defects.
Purpose of the Study:
- To explore novel therapeutic strategies for cancer treatment.
- To investigate the potential of biologically active peptides, particularly antimicrobial peptides (AMPs), in combating cancer.
Main Methods:
- Review of existing literature on cancer treatment resistance mechanisms.
- Analysis of the properties and mechanisms of action of antimicrobial peptides (AMPs).
- Exploration of peptide- and protein-based therapies in preclinical and clinical settings.
Main Results:
- Antimicrobial peptides (AMPs) demonstrate potent anticancer activities.
- AMPs can overcome common cancer drug resistance mechanisms.
- Peptide- and protein-based therapies represent a promising new avenue for cancer treatment.
Conclusions:
- Antimicrobial peptides (AMPs) present a viable and novel therapeutic approach for cancer.
- Targeting cancer with AMPs could overcome limitations of current chemotherapeutics.
- Further research into AMPs and proteins is crucial for developing next-generation cancer treatments.
Related Concept Videos
Cancer
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

